Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 252

1.

Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.

Pathela P, Jamison K, Papadouka V, Kabir R, Markowitz LE, Dunne EF, Schillinger JA.

J Adolesc Health. 2016 Sep 23. pii: S1054-139X(16)30230-0. doi: 10.1016/j.jadohealth.2016.07.021. [Epub ahead of print]

PMID:
27671357
2.

Prevalence of 9-Valent Human Papillomavirus Types by Race/Ethnicity in the Prevaccine Era, United States, 2003-2006.

Liu G, Unger ER, Hariri S, Steinau M, Markowitz LE.

Sex Transm Dis. 2016 Oct;43(10):633-6. doi: 10.1097/OLQ.0000000000000492.

PMID:
27631358
3.

Human Papillomavirus Vaccination and Age at First Sexual Activity, National Health and Nutrition Examination Survey.

Petrosky EY, Liu G, Hariri S, Markowitz LE.

Clin Pediatr (Phila). 2016 Sep 8. pii: 0009922816660541. [Epub ahead of print]

PMID:
27609513
4.

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2015.

Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Curtis CR, MacNeil J, Markowitz LE, Singleton JA.

MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):850-8. doi: 10.15585/mmwr.mm6533a4.

5.

Molecular Typing of Treponema pallidum in Ocular Syphilis.

Oliver S, Sahi SK, Tantalo LC, Godornes C, Neblett Fanfair R, Markowitz LE, Lukehart SA, Marra CM.

Sex Transm Dis. 2016 Aug;43(8):524-7. doi: 10.1097/OLQ.0000000000000478.

PMID:
27419819
6.

Human Papillomavirus-Associated Cancers - United States, 2008-2012.

Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M.

MMWR Morb Mortal Wkly Rep. 2016 Jul 8;65(26):661-6. doi: 10.15585/mmwr.mm6526a1.

7.

Monitoring for Human Papillomavirus Vaccine Impact Among Gay, Bisexual, and Other Men Who Have Sex With Men-United States, 2012-2014.

Meites E, Gorbach PM, Gratzer B, Panicker G, Steinau M, Collins T, Parrish A, Randel C, McGrath M, Carrasco S, Moore J, Zaidi A, Braxton J, Kerndt PR, Unger ER, Crosby RA, Markowitz LE.

J Infect Dis. 2016 Sep 1;214(5):689-96. doi: 10.1093/infdis/jiw232. Epub 2016 Jun 13.

PMID:
27296847
8.

Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis.

Laprise JF, Markowitz LE, Chesson HW, Drolet M, Brisson M.

J Infect Dis. 2016 Sep 1;214(5):685-8. doi: 10.1093/infdis/jiw227. Epub 2016 May 27.

PMID:
27234416
9.

Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines.

Burger EA, Lee K, Saraiya M, Thompson TD, Chesson HW, Markowitz LE, Kim JJ.

Cancer. 2016 Jul 1;122(13):2057-66. doi: 10.1002/cncr.30007. Epub 2016 Apr 28.

PMID:
27124396
10.

Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States.

Gee J, Weinbaum C, Sukumaran L, Markowitz LE.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1406-17. doi: 10.1080/21645515.2016.1168952. Epub 2016 Mar 30.

PMID:
27029786
11.

Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls.

Lindley MC, Jeyarajah J, Yankey D, Curtis CR, Markowitz LE, Stokley S.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1519-27. doi: 10.1080/21645515.2016.1157673. Epub 2016 Mar 22.

PMID:
27003108
12.

Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV Vaccine.

Chesson HW, Laprise JF, Brisson M, Markowitz LE.

J Infect Dis. 2016 Jun 1;213(11):1694-700. doi: 10.1093/infdis/jiw046. Epub 2016 Feb 9.

PMID:
26908738
13.

Prevalence of HPV After Introduction of the Vaccination Program in the United States.

Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER.

Pediatrics. 2016 Mar;137(3):e20151968. doi: 10.1542/peds.2015-1968. Epub 2016 Feb 22.

PMID:
26908697
14.

The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model.

Chesson HW, Markowitz LE, Hariri S, Ekwueme DU, Saraiya M.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1363-72. doi: 10.1080/21645515.2016.1140288. Epub 2016 Feb 18.

PMID:
26890978
15.

Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.

Williams WW, Lu PJ, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, Rodriguez-Lainz A, Bridges CB; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2016 Feb 5;65(1):1-36. doi: 10.15585/mmwr.ss6501a1.

PMID:
26844596
16.

Response to Pendleton et al. regarding reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States.

Hariri S, Markowitz LE, Unger ER.

Vaccine. 2016 Jan 4;34(2):201. doi: 10.1016/j.vaccine.2015.10.138. Epub 2015 Dec 2. No abstract available.

PMID:
26655631
17.

Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule.

Cloessner EA, Stokley S, Yankey D, Markowitz LE.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1375-80. doi: 10.1080/21645515.2015.1110659. Epub 2015 Nov 20.

PMID:
26587886
18.

Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States.

Brisson M, Laprise JF, Chesson HW, Drolet M, Malagón T, Boily MC, Markowitz LE.

J Natl Cancer Inst. 2015 Oct 4;108(1). pii: djv282. doi: 10.1093/jnci/djv282. Print 2016 Jan.

PMID:
26438574
19.

Seroprevalence of 9 Human Papillomavirus Types in the United States, 2005-2006.

Liu G, Markowitz LE, Hariri S, Panicker G, Unger ER.

J Infect Dis. 2016 Jan 15;213(2):191-8. doi: 10.1093/infdis/jiv403. Epub 2015 Aug 27.

PMID:
26320259
20.

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.

Hariri S, Markowitz LE, Bennett NM, Niccolai LM, Schafer S, Bloch K, Park IU, Scahill MW, Julian P, Abdullah N, Levine D, Whitney E, Unger ER, Steinau M, Bauer HM, Meek J, Hadler J, Sosa L, Powell SE, Johnson ML; Hpv-Impact Working Group.

Emerg Infect Dis. 2015 Sep;21(9):1557-61. doi: 10.3201/eid2109.141841.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk